What happens next in GLP-1 — and when.

What changed › 2026-09-14

Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy

Detected 2026-09-14 in the trials record for semaglutide, by comparing that day’s fetch against the previous one.

A completion date is the sponsor's estimate of when the main result will be in hand. ClinicalTrials.gov overwrites the old date when it moves, keeping no public history, so the previous value below exists nowhere else.

What changed

ChangeFieldValue
results date movedprimary_completion_date2031-09-30 → 2028-10-31

What the record says now

Status
Not yet recruiting
Phase
P2
Participants
100
Primary completion
2028-10-31
Sponsor
Population Health Research Institute

See semaglutide · NCT07511543 · the source record.

The previous value above is not recoverable from the source. Both ClinicalTrials.gov and the FDA revise records in place, keeping no public history, which is why this site keeps its own.

@glp1briefing